• 2019 GAPNA Pharmacology Conference: Contemporary Pharmacology and Prescribing in Older AdultsJoin us at the 2019 GAPNA Pharmacology Conference:
    Contemporary Pharmacology and Prescribing in Older Adults

    March 28-30, 2019, Chicago Hilton, Chicago, IL.

    Earn up to 11.5 CNE hours.

     

    Find out more about it and REGISTER today!

  • AwardCall for Excellence Award Nominations

    The awards are: Emerging Chapter Award, Established Chapter Excellence Award, Special Interest Group Excellence Award, Excellence in Clinical Practice Award, Excellence in Community Service Award, Excellence in Education Award, Excellence in Leadership Award, and Excellence in Research Award.

    The nominations are tallied in July and the winners are announced every year during the Awards Celebration at the GAPNA Annual Conference.

    Now is the time to nominate a colleague or yourself - DEADLINE is June 1, 2018.

    Get started... nominate today!

  • W A N T E D   G A P N A   L E A D E R S!
    Call for Nominations!

    Have you ever considered stepping forward, accepting the challenge and volunteering for a position on the 2019 National Board of Directors? Register online NOW by April 1, 2019!

    Step Up - NOW is the Time! Register Here>

  • FREE continuing education credit is available for the following session:

    "Keynote Address - Health Policy: APRNs Working to the Full Extent of the Law"

    (session captured at the GAPNA 2018 Annual Conference)


    For March/April 2019 - Get Your Free CNE Now!

  • Poster Presentation

       

    This 22-module curriculum provides a basic knowledge base for Nurse Practitioners who looking to advance their expertise in caring for patients with dementia.
     

    FREE to GAPNA members until September 1, 2019

  • GAPNA Exchange

       

    GAPNA Exchange is a private, secure community for members to share ideas, ask questions, lend expertise, and network with peers.

    It features both an Open Forum discussion area along with smaller, segmented communities.

    Interact with GAPNA members wherever and whenever!

    Go to GAPNA Exchange

Combination Chemotherapy Increases the Risk for Adverse Events in Elderly Patients with Colorectal Cancer

About 70% of colorectal cancers (CRC) develop in patients over the age of 65.

Treatment options in these elderly patients include the use of single-agent or combination-based chemotherapies. However, elderly patients are particularly vulnerable to side effects, especially when drugs are used in combination, according to researchers.

Medicare data were used to determine what types of chemotherapy, if any, these patients received. Patients who received chemotherapy tended to be younger, had more advanced cancers, and were more likely to be married compared to patients who did not get chemotherapy.

All patients, whether receiving chemotherapy or not, had a high incidence of symptoms and laboratory test abnormalities, which increased after patients began receiving chemotherapy. Compared to patients on fluorouracil alone, those on an oxaliplatin-based regimen had higher rates of adverse events, including nausea and neuropathy.

Those 70 years of age and older were more likely to experience certain adverse events such as infection, anemia, delirium, and heart disease.

For details, see Cen et al. (2012). Comparison of toxicity profiles of fluorouracil versus oxaliplatin regimens in a large population-based cohort of elderly patients with colorectal cancer. Annals of Oncology, 23(6), 1503-1511. doi:10.1093/annonc/mdr449

Related Topic 1: 

GAPNA Newsletter Issue: 

VIEW ALL ARTICLES: